Overview
The National Health (Minimum Stockholding) Amendment Determination (No. 10) 2026 amends the National Health (Minimum Stockholding) Determination 2023. The determination updates rules that require pharmaceutical suppliers to hold minimum stock levels of certain medicines listed under the National Health Act 1953.
What the Determination Covers
The amendment is split into two schedules with different start dates. Schedule 1 takes effect from 1 November 2026. Schedule 2 takes effect from 1 April 2027. The source material does not specify which medicines or pharmaceutical products are affected, or what the specific stockholding changes involve.
Administration
This determination is administered by the Department of Health, Disability and Ageing. It is relevant mainly to pharmaceutical wholesalers and suppliers covered by the existing minimum stockholding rules.
Key Actions
- Pharmaceutical wholesalers or suppliers subject to minimum stockholding rules can review the full legislative text at https://www.legislation.gov.au/F2026L01435 to identify which products or requirements change
- Note the two commencement dates: 1 November 2026 for Schedule 1 changes and 1 April 2027 for Schedule 2 changes, and check which applies to relevant stock lines
- The 'Set up an alert' feature on the Federal Register of Legislation page for this item can be used to be notified of further amendments
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.